Association Review
In brief
The association between GRIN3A (Glutamate Ionotropic Receptor NMDA Type Subunit 3A) and Epilepsy is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
11
Compounds
1
Trials
1of 2 via GRIN3A compounds
Publications
0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
11 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics
1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials
2 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
07
Provenance
References & sources
7 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access